Mitsu Chem Plast Q4 FY26: Margin Bounce, Furnastra Traction, and an IBC Expansion Bet

Mitsu Chem Plast Limited closed Q4 FY26 with a sharp improvement in profitability, even as topline stayed broadly stable year-on-year. For the quarter, total income came in at INR 86.79 crore, compared with INR 90.51 crore in Q4 FY25. The real change was in earnings quality: EBITDA rose to INR 14.23 crore and net profit increased to INR 7.72 crore, taking the EBITDA margin to 16.45% and net profit margin to 8.92%.

Management attributed the Q4 margin upswing to a combination of value addition, better operational efficiency, and product-mix improvement. It also acknowledged that a small part of the margin expansion came from war-linked raw material dynamics, and that such effects can reverse when polymer prices normalize.

Q4 FY26 performance: stronger earnings on stable revenue

Q4 FY26 revenue was INR 86.47 crore, with other income of INR 0.32 crore, taking total income to INR 86.79 crore. EBITDA at INR 14.23 crore was materially higher than the INR 8.23 crore in Q4 FY25. Net profit at INR 7.72 crore was more than double the INR 3.54 crore in the year-ago quarter.

The company’s commentary on margin sustainability was direct. Management indicated that a 9% to 10% EBITDA margin is fair for the business, and that 10% should be treated as a minimum baseline going forward, even if quarterly margins fluctuate.

FY26 snapshot: profitability recovery and lower leverage

For FY26, total income rose to INR 350.85 crore versus INR 332.88 crore in FY25. EBITDA increased to INR 34.66 crore and net profit to INR 15.62 crore. The EBITDA margin improved to 9.90% and PAT margin to 4.46%.

Balance sheet ratios disclosed in the presentation point to a more comfortable leverage position. Debt-to-equity reduced to 0.52x in FY26 from 0.71x in FY25, and interest coverage improved to 4.31x from 2.43x. ROE and ROCE also recovered to 13.89% and 15.64% respectively in FY26.

Working capital, however, moved in the opposite direction. The net operating cycle increased to 75 days in FY26, driven by higher debtor days (64) and inventory days (39). The operating cash flow reported for FY26 was INR 32.77 crore.

Revenue mix: packaging-led business with a higher-margin healthcare lane

The company operates across packaging products and healthcare furniture parts, supported by blow molding, injection molding, and custom molding capabilities. Segment-wise revenue data in the investor presentation shows that the business remains packaging-heavy.

In FY26, containers contributed INR 293.71 crore, furniture contributed INR 46.31 crore, and others contributed INR 10.15 crore. Management also described the mix in the concall as roughly 84% packaging and 16% furniture plus infrastructure.

The healthcare furniture parts vertical, positioned under the Furnastra brand, was highlighted as a key growth and margin driver. Management stated that Furnastra delivers 15% plus EBITDA margin, notably higher than the company-wide sustainable margin band of 9% to 10%.

Strategic focus: Unit expansion and the IBC entry

Two capacity-related threads stand out across the presentation and the call.

First, the company disclosed expansion activity for Unit IV beginning in 2026. The presentation also lists four facilities across Tarapur and Khalapur, with installed capacity of 29,900 plus MT per annum and machine base of 51 blow molding machines and 22 injection molding machines.

Second, the company announced a new strategic milestone on the earnings call: entry into the Intermediate Bulk Container (IBC) vertical via a fully automated IBC plant at the Khalapur facility. Management described it as an extension of the packaging platform, with demand potential across domestic and export markets. It also stated that the IBC business should carry a better margin profile than its existing container business due to fewer players, but did not quantify the expected margins, capex, or plant capacity. The only timeline stated was that the IBC plant is expected to start in Q2.

Guidance and what to track next

Management reiterated a long-term target of reaching INR 1,000 crore in annual revenue by FY28. On nearer-term guidance, it stated a target of minimum 30% growth in FY27, while clarifying that the growth is expected more in the second half of the year.

A key nuance from the call is the stated intent to prioritize bottom line over top line. Management said it may compromise on sales that are not profitable, focusing instead on value-added products and operating efficiency.

From an investor tracking standpoint, three variables will likely define how FY27 shapes up.

First is margin normalization. Management explicitly said part of the Q4 margin strength came from a temporary war-linked benefit and that it can reverse. Second is execution on the IBC initiative, especially whether the company shares clearer disclosures on capex, volumes, customer traction, and ramp-up once Q2 begins. Third is working capital management, given the longer operating cycle in FY26.

Mitsu Chem Plast’s Q4 FY26 print signals a business that has improved earnings quality, is attempting a structural mix shift through Furnastra, and is preparing to add a new packaging growth lever through IBC. The next few quarters should reveal whether the margin gains translate into a steadier base around the 10% level management has described as sustainable, while scaling capacity without stretching the balance sheet or working capital further.